Banner: investors

News Releases

Two National Restaurant Chains Adopt PURE® Hard Surface Disinfectant as a Food Safety Solution

September 07, 2016

PURE Control® Listed in Latest USDA/FSIS Update

SAN DIEGO (Sept. 7, 2016)  PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it had shipped orders for SDC-based PURE®  Hard Surface disinfectant to two national restaurant chains for use system wide as a food safety solution. Both restaurants (a leading Quick Service Restaurant [QSR] chain and a leading casual dining chain) completed previously announced testing/evaluations of PURE Hard Surface disinfectant, and have now placed initial orders totaling more than $250,000. They have each indicated that they plan to use PURE Hard Surface disinfectant system wide on  multiple  food contact  surfaces, as well as other surfaces susceptible to Norovirus contamination.

 Hank R. Lambert, Chief Executive Officer, said that, Use of our PURE Hard Surface disinfectant helps provide safer food for consumers and supports a restaurant’s brand protection. These restaurant chains recognize both the importance of using PURE Hard Surface disinfectant to replace less effective, toxic legacy sanitizer products in their stores - and the added value of PURE’s uniquely effective Norovirus elimination.

“We estimate that these two chains could generate over $1 million in combined annualized revenues. Four additional restaurant chains are in the midst of the product evaluation process to establish the benefits PURE Hard Surface disinfectant can provide them as a food safety and brand protection solution,” Lambert concluded.

 Powerful Green Antimicrobial Technology

PURE Hard Surface is distinguished from sanitizers being used in restaurant chains today by providing broad disinfectant-level pathogen reduction, including against Norovirus, without the requirement of rinsing food contact surfaces after application.

 PURE’s powerful SDC antimicrobial is distinguished as a fast acting eliminator of microorganisms (including Listeria, E. coli, Salmonella, Campylobactor and Norovirus) and other foodborne pathogens with the lowest toxicity in restaurant operations - increasing consumer and environmental safety.

 PURE Control® Listed in USDA’s FSIS Directive Update

PURE Control, the Company’s second antimicrobial food safety solution, is an FDA and USDA approved non-toxic direct food contact intervention to dramatically reduce pathogens including Salmonella. PURE Control is now listed in the August 25, 2016 revision to the USDA’s Food Safety and Inspection Service (FSIS) Directive 7120.1, “Safe and Suitable Ingredients Used in the Production of Meat, Poultry and Egg Products.”

 As previously announced, PURE received a “No Objection Letterfrom the USDA’s FSIS granting approval for SDC-based PURE Control to be used as a spray or dip applied to poultry carcasses, parts and organs in pre-OLR (on-line reprocessing) and post chill processing of fresh poultry. PURE continues its on-going plant trials to optimize the application of PURE Control in OLR to gain USDA approval for use in that stage of poultry processing.

 
About PURE Bioscience, Inc.

PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products primarily in the food safety arena -- providing solutions to the health and environmental challenges of pathogen and hygienic control. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and it mitigates bacterial resistance. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

 

Forward-looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from any forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including the Company’s ability to convert successful evaluations into customer orders and customers continuing to place product orders as expected and to expand their use of the Company’s products; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw meat processing and to expand its use in OLR poultry processing; competitive factors; dependence upon third- party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2015, its Form 10-Q for the first quarter ended October 31, 2015 and its Form 10-Q for the second quarter ended January 31, 2016, and its Form 10-Q for the third quarter ended April 30, 2016. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

 

 

Contacts:

 

Hank Lambert, CEO

Terri MacInnis, VP of IR

Tom Hemingway

PURE Bioscience, Inc.

Bibicoff + MacInnis, Inc.

Redwood Investment Group

619-596-8600 ext.103

818-379-8500

714-978-4425

hlambert@purebio.com

terri@bibimac.com

tomh@redwoodfin.com